MEI Pharma, Inc. Share Price Börse Stuttgart
Equities
MMI0
US55279B3015
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.272 EUR | +0.38% | +1,961.78% | +1,757.39% |
Sales 2024 * | 65.3M 60.42M 5.45B | Sales 2025 * | 6.25M 5.78M 522M | Capitalization | 18.79M 17.38M 1.57B |
---|---|---|---|---|---|
Net income 2024 * | 26M 24.06M 2.17B | Net income 2025 * | -40M -37.01M -3.34B | EV / Sales 2024 * | 0.29 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 3.01 x |
P/E ratio 2024 * |
0.78
x | P/E ratio 2025 * |
-0.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.3% |
Latest transcript on MEI Pharma, Inc.
1 week | +1,961.78% | ||
1 month | +1,710.17% | ||
3 months | +1,373.10% | ||
6 months | +1,042.25% | ||
Current year | +1,757.39% |
Managers | Title | Age | Since |
---|---|---|---|
David Urso
CEO | Chief Executive Officer | 60 | 07/14/07 |
Justin File
DFI | Director of Finance/CFO | 53 | 12/23/12 |
Caroline Ruiz
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 73 | 26/18/26 |
Thomas Reynolds
BRD | Director/Board Member | 65 | 11/13/11 |
Charles Baltic
CHM | Chairman | 63 | 20/11/20 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.19% | 59.28B | |
+41.42% | 40.94B | |
-5.60% | 40.17B | |
-5.16% | 28.69B | |
+12.69% | 26.63B | |
-20.80% | 18.89B | |
+30.40% | 12.46B | |
+0.08% | 12.42B | |
+26.19% | 12.26B |
- Stock Market
- Equities
- MEIP Stock
- MMI0 Stock